nach oben

Zeitschrift für Gerontologie und Geriatrie

Erschienen in:

01.07.2016 | CME Zertifizierte Fortbildung

Depressionen im höheren Lebensalter, Teil 2

Komorbidität und Behandlung

verfasst von: Dr. Dirk K. Wolter

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Depressionen des höheren Lebensalters wirken sich ungünstig auf die Prognose komorbider somatischer Erkrankungen aus. Mit verschiedenen häufigen Erkrankungen (Diabetes mellitus, ischämische Herzkrankheit, Schlaganfall, M. Parkinson) besteht eine reziproke wechselseitige Risikoerhöhung. Für die Behandlung steht eine breite Palette nichtsomatischer und somatischer Methoden, einschließlich spezieller Interventionen zur Wirkungsverstärkung bzw. bei Therapieresistenz, zur Verfügung.

Vorheriger Artikel Erratum zu: Überleitung zwischen Häuslichkeit und Kurzeitpflege

Nächster Artikel Kognitive Verhaltenstherapie mit depressiven geriatrischen Patienten

S3-Leitlinie / Nationale VersorgungsLeitlinie Unipolare Depression. 2. Auflage 2015. http://www.awmf.org/leitlinien/detail/ll/nvl-005.html Zugriff 23.1.2016

Rotella F, Mannucci E (2013) Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract 99(2):98–104. doi:10.1016/j.diabres.2012.11.022 CrossRefPubMed

Rotella F, Mannucci E (2013) Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 74(1):31–37. doi:10.4088/JCP.12r07922 CrossRefPubMed

van Dooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F (2013) Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS One 8(3):e57058. doi:10.1371/journal.pone.0057058 CrossRefPubMedPubMedCentral

Siddiqui S (2014) Depression in type 2 diabetes mellitus – a brief review. Diabetes Metab Syndr 8(1):62–65. doi:10.1016/j.dsx.2013.06.010 CrossRefPubMed

Charlson FJ, Moran AE, Freedman G, Norman RE, Stapelberg NJ, Baxter AJ, Vos T, Whiteford HA (2013) The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med 11:250. doi:10.1186/1741-7015-11-250 CrossRefPubMedPubMedCentral

Baune BT, Stuart M, Gilmour A, Wersching H, Arolt V, Berger K (2012) Moderators of the relationship between depression and cardiovascular disorders: a systematic review. Gen Hosp Psychiatry 34(5):478–492. doi:10.1016/j.genhosppsych.2012.05.013 CrossRefPubMed

Elderon L, Whooley MA (2013) Depression and cardiovascular disease. Prog Cardiovasc Dis 55(6):511–523. doi:10.1016/j.pcad.2013.03.010 CrossRefPubMed

Larsen KK (2013) Depression following myocardial infarction – an overseen complication with prognostic importance. Dan Med J 60(8):B4689PubMed

10.

Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P (2011) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 33(3):203–216. doi:10.1016/j.genhosppsych.2011.02.007 CrossRefPubMed

11.

Hackett ML, Pickles K (2014) Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 9(8):1017–1025. doi:10.1111/ijs.12357 CrossRefPubMed

12.

Barlinn K, Kepplinger J, Puetz V, Illigens BM, Bodechtel U, Siepmann T (2014) Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis. Neuropsychiatr Dis Treat 11:1–14. doi:10.2147/NDT.S63904 CrossRefPubMedPubMedCentral

13.

Johnson JL, Minarik PA, Nyström KV, Bautista C, Gorman MJ (2006) Poststroke depression incidence and risk factors: an integrative literature review. J Neurosci Nurs 38(4 Suppl):316–327CrossRefPubMed

14.

De Ryck A, Fransen E, Brouns R, Geurden M, Peij D, Mariën P, De Deyn PP, Engelborghs S (2014) Poststroke depression and its multifactorial nature: results from a prospective longitudinal study. J Neurol Sci 347(1–2):159–166. doi:10.1016/j.jns.2014.09.038 CrossRefPubMed

15.

Snaphaan L, van der Werf S, Kanselaar K, de Leeuw FE (2009) Post-stroke depressive symptoms are associated with post-stroke characteristics. Cerebrovasc Dis 28(6):551–557. doi:10.1159/000247598 CrossRefPubMed

16.

Wei N, Yong W, Li X, Zhou Y, Deng M, Zhu H, Jin H (2015) Post-stroke depression and lesion location: a systematic review. J Neurol 262(1):81–90. doi:10.1007/s00415-014-7534-1 CrossRefPubMed

17.

Brookes RL, Herbert V, Lawrence AJ, Morris RG, Markus HS (2014) Depression in small-vessel disease relates to white matter ultrastructural damage, not disability. Neurology 83(16):1417–1423. doi:10.1212/WNL.0000000000000882 CrossRefPubMedPubMedCentral

18.

Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML (2012) Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev (11):CD009286. doi:10.1002/14651858.CD009286.pub2

19.

Ihle-Hansen H, Thommessen B, Fagerland MW, Oksengård AR, Wyller TB, Engedal K, Fure B (2014) Effect on anxiety and depression of a multifactorial risk factor intervention program after stroke and TIA: a randomized controlled trial. Aging Ment Health 18(5):540–546. doi:10.1080/13607863.2013.824406 CrossRefPubMed

20.

Gustafsson H, Nordström A, Nordström P (2015) Depression and subsequent risk of Parkinson disease: a nationwide cohort study. Neurology. doi:10.1212/WNL.0000000000001684

21.

Biemiller R, Richard IH (2014) Managing depression in Parkinson’s patients: risk factors and clinical pearls. Neurodegener Dis Manag 4(4):329–336. doi:10.2217/nmt.14.31 CrossRefPubMed

22.

Rod NH, Bordelon Y, Thompson A, Marcotte E, Ritz B (2013) Major life events and development of major depression in Parkinson’s disease patients. Eur J Neurol 20(4):663–670. doi:10.1111/ene.12019 CrossRefPubMed

23.

Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P (2015) Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 14(5):518–531. doi:10.1016/S1474-4422(15)00019-8 CrossRefPubMed

24.

Loas G, Duru C, Godefroy O, Krystkowiak P (2014) Hedonic deficits in Parkinson’s disease: is consummatory anhedonia specific? Front Neurol 5:24. doi:10.3389/fneur.2014.00024 CrossRefPubMedPubMedCentral

25.

Riedel O, Dodel R, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Wittchen HU (2011) Demenz und Depression determinieren Pflegebedürftigkeit bei M. Parkinson. Nervenarzt 82(8):1012–1019. doi:10.1007/s00115-010-3186-2 CrossRefPubMed

26.

Liu J, Dong J, Wang L, Su Y, Yan P, Sun S (2013) Comparative efficacy and acceptability of antidepressants in Parkinson’s disease: a network meta-analysis. PLoS One 8(10):e76651. doi:10.1371/journal.pone.0076651 CrossRefPubMedPubMedCentral

27.

Riedel O, Dodel R, Rohde K, Wittchen HU (2013) Depression bei Morbus Parkinson – Epidemiologie und Therapie. Akt Neurol 40:574–587CrossRef

28.

Löffler LA, Radke S, Morawetz C, Derntl B (2015) Emotional dysfunctions in neurodegenerative diseases. J Comp Neurol. doi:10.1002/cne.23816

29.

Hawker GA, Gignac MA, Badley E, Davis AM, French MR, Li Y, Perruccio AV, Power JD, Sale J, Lou W (2011) A longitudinal study to explain the pain-depression link in older adults with osteoarthritis. Arthritis Care Res (Hoboken) 63(10):1382–1390. doi:10.1002/acr.20298 CrossRef

30.

Fan VS, Meek PM (2014) Anxiety, depression, and cognitive impairment in patients with chronic respiratory disease. Clin Chest Med 35(2):399–409. doi:10.1016/j.ccm.2014.02.012 CrossRefPubMed

31.

Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF (2013) Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 84(1):179–191. doi:10.1038/ki.2013.77 CrossRefPubMed

32.

Farrokhi F, Abedi N, Beyene J, Kurdyak P, Jassal SV (2014) Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. Am J Kidney Dis 63(4):623–635. doi:10.1053/j.ajkd.2013.08.024 CrossRefPubMed

33.

Li Z, Li Y, Chen L, Chen P, Hu Y (2015) Prevalence of depression in patients with hypertension: a systematic review and meta-analysis. Medicine (Baltimore) 94(31):e1317. doi:10.1097/MD.0000000000001317 CrossRef

34.

Ittermann T, Völzke H, Baumeister SE, Appel K, Grabe HJ (2015) Diagnosed thyroid disorders are associated with depression and anxiety. Soc Psychiatry Psychiatr Epidemiol. doi:10.1007/s00127-015-1043-0

35.

Baumgartner C, Blum MR, Rodondi N (2014) Subclinical hypothyroidism: summary of evidence in 2014. Swiss Med Wkly 144:w14058. doi:10.4414/smw.2014.14058 PubMed

36.

Madeira N, Santos T (2011) Depression: an unrecognized presentation of hyperthyroidism in old age. Eur Geriatr Med 2:305–306. doi:10.1016/j.eurger.2011.05.008 CrossRef

37.

Cosci F, Fava GA, Sonino N (2015) Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom 84(1):22–29. doi:10.1159/000367913 CrossRefPubMed

38.

Smith DJ, Court H, McLean G, Martin D, Langan Martin J, Guthrie B, Gunn J, Mercer SW (2014) Depression and multimorbidity: a cross-sectional study of 1,751,841 patients in primary care. J Clin Psychiatry 75(11):1202–1208; quiz 1208. doi:10.4088/JCP.14m09147 CrossRefPubMed

39.

Gühne U, Luppa M, König HH, Hautzinger M, Riedel-Heller S (2014) Ist Psychotherapie bei depressiven Erkrankungen im Alter wirksam? Ein systematischer Überblick. Psychiat Prax 41:415–423. doi 10.1055/s-0034-1370113 CrossRef

40.

Huang AX, Delucchi K, Dunn LB, Nelson JC (2015) A systematic review and meta-analysis of psychotherapy for late-life depression. Am J Geriatr Psychiatry 23(3):261–273. doi:10.1016/j.jagp.2014.04.003 CrossRefPubMed

41.

Wächtler C (2013) Psychotherapie der Altersdepression. Z Gerontol Geriatr 46(2):120–126. doi:10.1007/s00391-012-0469-1 CrossRefPubMed

42.

Cuijpers P, Karyotaki E, Pot AM, Park M, Reynolds CF 3rd (2014) Managing depression in older age: psychological interventions. Maturitas 79(2):160–169. doi:10.1016/j.maturitas.2014.05.027 CrossRefPubMedPubMedCentral

43.

Francis JL, Kumar A (2013) Psychological treatment of late-life depression. Psychiatr Clin North Am 36(4):561–575. doi:10.1016/j.psc.2013.08.005 CrossRefPubMed

44.

Driessen E, Hegelmaier LM, Abbass AA, Barber JP, Dekker JJ, Van HL, Jansma EP, Cuijpers P (2015) The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update. Clin Psychol Rev 42:1–15. doi:10.1016/j.cpr.2015.07.004 CrossRefPubMed

45.

Dykierek P, Schramm E (2000) Interpersonelle Psychotherapie zur Behandlung von Altersdepressionen. In: Bäurle P, Radebold H, Hirsch RD, Studer K, Schmid-Forstoss U, Struwe B (Hrsg) Klinische Psychotherapie mit älteren Menschen. Huber, Bern, S 95–100

46.

Koenig AM, Butters MA (2014) Cognition in late life depression: treatment considerations. Curr Treat Options Psychiatry 1(1):1–14CrossRefPubMed

47.

Miller MD (2008) Using interpersonal therapy (IPT) with older adults today and tomorrow: a review of the literature and new developments. Curr Psychiatry Rep 10(1):16–22CrossRefPubMed

48.

Bohlmeijer E, Smit F, Cuijpers P (2003) Effects of reminiscence and life review on late-life depression: a meta-analysis. Int J Geriatr Psychiatry 18(12):1088–1094CrossRefPubMed

49.

Wolfersdorf M, Schüler M (2005) Depressionen im Alter. Kohlhammer, Stuttgart

50.

Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis G, Watkins E, Brejcha C, Cardy J, Causley A, Cowderoy S, Evans A, Gradinger F, Kaur S, Lanham P, Morant N, Richards J, Shah P, Sutton H, Vicary R, Weaver A, Wilks J, Williams M, Taylor RS, Byford S (2015) Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet 386(9988):63–73. doi:10.1016/S0140-6736(14)62222-4 CrossRefPubMed

51.

Wood SK (2014) Individual differences in the neurobiology of social stress: implications for depression-cardiovascular disease comorbidity. Curr Neuropharmacol 12(2):205–211CrossRefPubMedPubMedCentral

52.

Vittengl JR, Jarrett RB (2015) Cognitive therapy to prevent depressive relapse in adults. Curr Opin Psychol 4:26–31. http://dx.doi.org/10.1016/j.copsyc.2015.01.016 CrossRefPubMed

53.

Adler G (2005) Verhaltens-Einzelpsychotherapie von Depressionen im Alter (VEDIA). Schattauer, Stuttgart

54.

Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D, McCulloch C, Areán PA (2011) Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry 68(1):33–41. doi:10.1001/archgenpsychiatry.2010.177 CrossRefPubMedPubMedCentral

55.

Choi NG, Marti CN, Bruce ML, Hegel MT (2013) Depression in homebound older adults: problem-solving therapy and personal and social resourcefulness. Behav Ther 44(3):489–500. doi:10.1016/j.beth.2013.04.002 CrossRefPubMedPubMedCentral

56.

Simon SS, Cordás TA, Bottino CM (2015) Cognitive Behavioral Therapies in older adults with depression and cognitive deficits: a systematic review. Int J Geriatr Psychiatry 30(3):223–233. doi:10.1002/gps.4239 CrossRefPubMed

57.

Miller MD, Reynolds CF 3rd (2007) Expanding the usefulness of Interpersonal Psychotherapy (IPT) for depressed elders with co-morbid cognitive impairment. Int J Geriatr Psychiatry 22(2):101–105CrossRefPubMed

58.

Moretti F, De Ronchi D, Bernabei V, Marchetti L, Ferrari B, Forlani C, Negretti F, Sacchetti C, Atti AR (2011) Pet therapy in elderly patients with mental illness. Psychogeriatrics 11(2):125–129. doi:10.1111/j.1479-8301.2010.00329.x CrossRefPubMed

59.

Michalak J, Rohde K, Troje NF (2015) How we walk affects what we remember: gait modifications through biofeedback change negative affective memory bias. J Behav Ther Exp Psychiatry 46:121–125. doi:10.1016/j.jbtep.2014.09.004 CrossRefPubMed

60.

Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R (2009) Rochester G: risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339:b2880. doi:10.1136/bmj.b2880 CrossRefPubMedPubMedCentral

61.

Bschor T, Bauer M, Adli M (2014) Chronische und therapieresistente Depression – Diagnostik und Stufentherapie. Chronic and treatment resistant depression – diagnosis and stepwise therapy. Dtsch Arztebl Int 111:766–776. doi:10.3238/arztebl.2014.0766 PubMedPubMedCentral

62.

Holthoff V (2013) Pharmakotherapie der Altersdepression. Z Gerontol Geriatr 46(2):112–119. doi:10.1007/s00391-013-0476-x CrossRefPubMed

63.

Katona C, Bindman DC, Katona CP (2014) Antidepressants for older people: what can we learn from the current evidence base? Maturitas 79(2):174–178. doi:10.1016/j.maturitas.2014.05.016 CrossRefPubMed

64.

Kok RM, Heeren TJ, Nolen WA (2011) Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants. Am J Geriatr Psychiatry 19(3):249–255CrossRefPubMed

65.

Mulsant BH, Blumberger DM, Ismail Z, Rabheru K, Rapoport MJ (2014) A systematic approach to pharmacotherapy for geriatric major depression. Clin Geriatr Med 30(3):517–534. doi:10.1016/j.cger.2014.05.002 CrossRefPubMedPubMedCentral

66.

Benkert O, Hippius H (2015) Kompendium der Psychiatrischen Pharmakotherapie, 10. Aufl. Springer, Heidelberg

67.

Kok RM, Aartsen M, Nolen WA, Heeren T (2009) The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression. J Am Geriatr Soc 57(11):2112–2117CrossRefPubMed

68.

Mulsant BH, Pollock BG (2015) Psychopharmacology. In: Steffens DC, Blazer DG, Thakur ME (Hrsg) Textbook of geriatric psychiatry, 5. Aufl. American Psychiatric Publishing, Washington DC, S 527–587

69.

Oka Y, Okamoto K, Kawashita N, Shirakuni Y, Takagi T (2014) Meta-analysis of the risk of upper gastrointestinal hemorrhage with combination therapy of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Biol Pharm Bull 37(6):947–953CrossRefPubMed

70.

Kronenberg S (2011) Anti-inflammatory drugs as moderators of antidepressant effects, especially those of the selective serotonin-reuptake inhibitor class. Expert Rev Clin Pharmacol 4(5):575–578. doi:10.1586/ecp.11.47 CrossRefPubMed

71.

Donoghue OA, O’Hare C, King-Kallimanis B, Kenny RA (2015) Antidepressants are independently associated with gait deficits in single and dual task conditions. Am J Geriatr Psychiatry 23(2):189–199. doi:10.1016/j.jagp.2014.04.005 CrossRefPubMed

72.

Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI (2011) Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry 72(12):1660–1668. doi:10.4088/JCP.10r06531 CrossRefPubMed

73.

Nelson JC, Delucchi KL, Schneider LS (2013) Moderators of outcome in late-life depression: a patient-level meta-analysis. Am J Psychiatry 170(6):651–659. doi:10.1176/appi.ajp.2012.12070927 CrossRefPubMed

74.

Pimontel MA, Rindskopf D, Rutherford BR, Brown PJ, Roose SP, Sneed JR (2015) A meta-analysis of executive dysfunction and antidepressant treatment response in late-life depression. Am J Geriatr Psychiatry. pii: S1064-7481(15)00180-3. doi:10.1016/j.jagp.2015.05.010

75.

Sneed JR, Culang ME, Keilp JG, Rutherford BR, Devanand DP, Roose SP (2010) Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression. Am J Geriatr Psychiatry 18(2):128–135. doi:10.1097/JGP.0b013e3181c796d2 CrossRefPubMedPubMedCentral

76.

Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O’Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A (2013) Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess 17(7):1–166. doi:10.3310/hta17070 CrossRefPubMedPubMedCentral

77.

Leong C (2014) Antidepressants for depression in patients with dementia: a review of the literature. Consult Pharm 29(4):254–263. doi:10.4140/TCP.n.2014.254 CrossRefPubMed

78.

Nelson JC, Devanand DP (2011) A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia. J Am Geriatr Soc 59(4):577–585 doi:10.1111/j.1532-5415.2011.03355.x CrossRefPubMed

79.

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG (2014) CitAD Research Group: effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 311(7):682–691. doi:10.1001/jama.2014.93 CrossRefPubMedPubMedCentral

80.

Gutzmann H, Qazi A (2015) Depression associated with dementia. Z Gerontol Geriatr 48(4):305–311. doi:10.1007/s00391-015-0898-8 CrossRefPubMed

81.

Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M (2014) Role of lithium augmentation in the management of major depressive disorder. CNS Drugs 28(4):331–342. doi:10.1007/s40263-014-0152-8 CrossRefPubMed

82.

Cooper C, Katona C, Lyketsos K, Blazer D, Brodaty H, Rabins P, de Mendonça LCA, Livingston G (2011) A systematic review of treatments for refractory depression in older people. Am J Psychiatry 168(7):681–688. doi:10.1176/appi.ajp.2011.10081165 CrossRefPubMed

83.

Turner P, Kantaria R, Young AH (2014) A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: a European perspective. J Psychopharmacol 28(2):85–98. doi:10.1177/0269881113507640 CrossRefPubMed

84.

Almeida OP, Ford AH, Hirani V, Singh V, vanBockxmeer FM, McCaul K, Flicker L (2014) B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial. Br J Psychiatry 205(6):450–457. doi:10.1192/bjp.bp.114.145177 CrossRefPubMed

85.

Wijeratne C, Draper B (2011) Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity. Aust N Z J Psychiatry 45(12):1026–1032. doi:10.3109/00048674.2011.610296 CrossRefPubMed

86.

Iadarola ND, Niciu MJ, Richards EM, Vande Voort JL, Ballard ED, Lundin NB, Nugent AC, Machado-Vieira R, Zarate CA Jr (2015) Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis 6(3):97–114. doi:10.1177/2040622315579059 CrossRefPubMedPubMedCentral

87.

Bunney BG, Li JZ, Walsh DM, Stein R, Vawter MP, Cartagena P, Barchas JD, Schatzberg AF, Myers RM, Watson SJ, Akil H, Bunney WE (2015) Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry 20(1):48–55. doi:10.1038/mp.2014.138 CrossRefPubMed

88.

McCall WV, Andrade C, Sienaert P (2014) Searching for the mechanism(s) of ECT’s therapeutic effect. J ECT 30(2):87–89. doi:10.1097/YCT.0000000000000121 CrossRefPubMedPubMedCentral

89.

Dallaspezia S, Benedetti F (2011) Chronobiological therapy for mood disorders. Expert Rev Neurother 11(7):961–970. doi:10.1586/ern.11.61 CrossRefPubMed

90.

Lieverse R, Van Someren EJ, Nielen MM, Uitdehaag BM, Smit JH, Hoogendijk WJ (2011) Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry 68(1):61–70. doi:10.1001/archgenpsychiatry.2010.183 CrossRefPubMed

91.

Dombrovski AY, Mulsant BH (2007) The evidence for electroconvulsive therapy (ECT) in the treatment of severe late-life depression. ECT: the preferred treatment for severe depression in late life. Int Psychogeriatr 19(1):10–14, 27–35CrossRefPubMed

92.

Rhebergen D, Huisman A, Bouckaert F, Kho K, Kok R, Sienaert P, Spaans HP, Stek M (2015) Older age is associated with rapid remission of depression after electroconvulsive therapy: a latent class growth analysis. Am J Geriatr Psychiatry 23(3):274–282. doi:10.1016/j.jagp.2014.05.002 CrossRefPubMed

93.

Spaans HP, Sienaert P, Bouckaert F, van den Berg JF, Verwijk E, Kho KH, Stek ML, Kok RM (2015) Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry 206(1):67–71. doi:10.1192/bjp.bp.114.148213 CrossRefPubMed

94.

Schwerthöffer D, Wolf F, Pitschel-Walz G, Bäuml J (2011) Verkürzt eine frühzeitige Elektrokrampftherapie bei schweren depressiven Episoden die weitere stationäre Behandlungsdauer? Psychiatr Prax 38(2):77–81. doi:10.1055/s-0030-1248600 CrossRefPubMed

95.

Mulder ME, Verwey B, van Waarde JA (2012) Electroconvulsive therapy in a terminally ill patient: when every day of improvement counts. J ECT 28(1):52–53. doi:10.1097/YCT.0b013e3182321181 CrossRefPubMed

96.

Gardner BK, O’Connor DW (2008) A review of the cognitive effects of electroconvulsive therapy in older adults. J ECT 24(1):68–80. doi:10.1097/YCT.0b013e318165c7b0 CrossRefPubMed

97.

Volkmar S (2013) Gerontopsychosomatik und Alterspsychotherapie. Grundlagen und Behandlung aus verhaltenstherapeutischer Sicht. Kohlhammer, Stuttgart

98.

Wojnar J, Bruder J (1995) Psychotherapeutische Unterstützung pflegebedürftiger alter Menschen in Heimen. Z Gerontopsychol Psychiatr 8:163–168

Titel: Depressionen im höheren Lebensalter, Teil 2
Komorbidität und Behandlung
verfasst von: Dr. Dirk K. Wolter
Publikationsdatum: 01.07.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Zeitschrift für Gerontologie und Geriatrie / Ausgabe 5/2016
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI: https://doi.org/10.1007/s00391-016-1022-4

Der De Morton Mobility Index zur Evaluation der geriatrischen Frührehabilitation

Originalien

Lungenfunktion bei älteren Probanden mit metabolischem Syndrom und Typ-2-Diabetes

Originalien

Erratum zu: Überleitung zwischen Häuslichkeit und Kurzeitpflege

Erratum

Mitteilungen der DGG

Mitteilungen der DGG

Mitteilungen des Bundesverbands Geriatrie

Mitteilungen des Bundesverbands Geriatrie

Outdoor motivation moderates the effects of accessibility on mobility in old age

Originalien

Springerpflege

Depressionen im höheren Lebensalter, Teil 2

Komorbidität und Behandlung

Zusammenfassung

Weitere Artikel der Ausgabe 5/2016

Der De Morton Mobility Index zur Evaluation der geriatrischen Frührehabilitation

Lungenfunktion bei älteren Probanden mit metabolischem Syndrom und Typ-2-Diabetes

Erratum zu: Überleitung zwischen Häuslichkeit und Kurzeitpflege

Mitteilungen der DGG

Mitteilungen des Bundesverbands Geriatrie

Outdoor motivation moderates the effects of accessibility on mobility in old age

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Der De Morton Mobility Index zur Evaluation der geriatrischen Frührehabilitation

Lungenfunktion bei älteren Probanden mit metabolischem Syndrom und Typ-2-Diabetes

Erratum zu: Überleitung zwischen Häuslichkeit und Kurzeitpflege

Mitteilungen der DGG

Mitteilungen des Bundesverbands Geriatrie

Outdoor motivation moderates the effects of accessibility on mobility in old age